Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 19 de 19
Filter
Add more filters










Publication year range
1.
Vet Comp Oncol ; 18(4): 739-752, 2020 Dec.
Article in English | MEDLINE | ID: mdl-32329214

ABSTRACT

Canine B-cell lymphoma is one of the most common haematopoietic neoplasms in veterinary medicine, and it is considered a relevant model for human diffuse large B-cell lymphoma. Although the standard treatment consisting of multi-drug chemotherapy is effective in most cases, treatment is often challenging because of relapse and drug resistance. The adoptive transfer of autologous T cells genetically modified to express a CD19-specific chimeric antigen receptor (CD19 CAR-T cells) has been shown to be highly effective in human B-cell malignancies. However, there is no clinically available canine CAR-T cell therapy. We generated canine second-generation and third-generation CAR-T cells by retroviral gene transduction. Optimization was performed to investigate effective viral transduction protocols and favourable culture conditions for canine CAR-T cells. The RetroNectin-bound virus infection method resulted in more than 70% transduction efficiency. The effect of culture conditions on the phenotype of CAR-T cells was evaluated by the expression of surface markers. in vitro cytotoxicity assays of target cells cultured with CD20 CAR-transduced cells demonstrated that CD20 CAR-T cells exhibit cytotoxicity against CD20-expressing canine B-cell lymphoma cells and canine CD20-transduced murine cells, whereas no effect was observed against cells that lacked canine CD20 expression. Our study established virus-based canine CAR-T cell generation, providing fundamental data for a better understanding of canine adoptive T-cell therapy.


Subject(s)
Dog Diseases/therapy , Immunotherapy, Adoptive/veterinary , Lymphoma, B-Cell/veterinary , Receptors, Antigen, T-Cell/therapeutic use , Receptors, Chimeric Antigen/therapeutic use , Animals , Antigens, CD19/genetics , Antigens, CD19/immunology , Antigens, CD19/metabolism , Antigens, CD20/genetics , Antigens, CD20/immunology , Antigens, CD20/metabolism , Cell Line, Tumor , Dogs , Immunotherapy, Adoptive/methods , Lymphoma, B-Cell/therapy , Transduction, Genetic/veterinary
2.
Viruses ; 11(12)2019 11 23.
Article in English | MEDLINE | ID: mdl-31771194

ABSTRACT

Foamy viruses (FVs) are nonpathogenic retroviruses that infect various animals including bovines, felines, nonhuman primates (NHPs), and can be transmitted to humans through zoonotic infection. Due to their non-pathogenic nature, broad tissue tropism and relatively safe integration profile, FVs have been engineered as novel vectors (foamy virus vector, FVV) for stable gene transfer into different cells and tissues. FVVs have emerged as an alternative platform to contemporary viral vectors (e.g., adeno associated and lentiviral vectors) for experimental and therapeutic gene therapy of a variety of monogenetic diseases. Some of the important features of FVVs include the ability to efficiently transduce hematopoietic stem and progenitor cells (HSPCs) from humans, NHPs, canines and rodents. We have successfully used FVV for proof of concept studies to demonstrate safety and efficacy following in-vivo delivery in large animal models. In this review, we will comprehensively discuss FVV based in-vivo gene therapy approaches established in the X-linked severe combined immunodeficiency (SCID-X1) canine model.


Subject(s)
Genetic Therapy , Genetic Vectors , Spumavirus/genetics , X-Linked Combined Immunodeficiency Diseases/veterinary , Animals , Cats , Cattle , Disease Models, Animal , Dogs , Hematopoietic Stem Cells/physiology , Humans , Stem Cells/physiology , Transduction, Genetic/veterinary , X-Linked Combined Immunodeficiency Diseases/genetics , X-Linked Combined Immunodeficiency Diseases/therapy
3.
J Feline Med Surg ; 19(6): 680-686, 2017 Jun.
Article in English | MEDLINE | ID: mdl-27354226

ABSTRACT

Objectives The goals of the study were: (1) to develop and evaluate non-replicating lentivirus vectors coding for feline coronavirus (FCoV)-specific micro (mi)RNA as a potential antiviral therapy for feline infectious peritonitis (FIP); (2) to assess the feasibility of transducing hematopoietic stem cells (HSCs) with ex vivo introduction of the miRNA-expressing lentivirus vector; and (3) to assess the ability of the expressed miRNA to inhibit FCoV replication in HSCs in vitro. Methods HSCs were obtained from feline bone marrow and replicated in vitro. Three lentiviruses were constructed, each expressing a different anti-FCoV miRNA. HSCs were stably transduced with the miRNA-expressing lentivirus vector that produced the most effective viral inhibition in a feline cell line. The effectiveness of the transduction and the expression of anti-FCoV miRNA were tested by infecting the HSCs with two different strains of FCoV. The inhibition of coronavirus replication was determined by relative quantification of the inhibition of intracellular viral genomic RNA synthesis using real-time, reverse-transcription PCR. The assessment of virus replication inhibition was determined via titration of extracellular virus using the TCID50 assay. Results Inhibition of FCoV was most significant in feline cells expressing miRNA-L2 that targeted the viral leader sequence, 48 h postinfection. miRNA-L2 expression in stably transduced HSCs resulted in 90% and 92% reductions in FIPV WSU 79-1146 genomic RNA synthesis and extracellular virus production, respectively, as well as 74% and 80% reduction in FECV WSU 79-1683 genomic RNA synthesis and extracellular virus production, respectively, as compared with an infected negative control sample producing non-targeting miRNA. Conclusions and relevance These preliminary results show that genetic modification of HSCs for constitutive production of anti-coronavirus miRNA will reduce FCoV replication.


Subject(s)
Antiviral Agents/therapeutic use , Coronavirus, Feline/genetics , Feline Infectious Peritonitis/virology , RNA, Small Interfering/therapeutic use , Animals , Antiviral Agents/pharmacology , Cats , Feline Infectious Peritonitis/drug therapy , RNA Interference , RNA, Small Interfering/pharmacology , Real-Time Polymerase Chain Reaction/veterinary , Transduction, Genetic/veterinary , Virus Replication/drug effects
4.
BMC Vet Res ; 11: 264, 2015 Oct 15.
Article in English | MEDLINE | ID: mdl-26472464

ABSTRACT

BACKGROUND: Classical swine fever (CSF) caused by CSF virus (CSFV) is highly contagious andcauses significant economic losses in the pig industry throughout the world. Previously we demonstrated that porcine Mx1 (poMx1), when fused to HIV Tat protein transduction domain (PTD), inhibits CSFV propagation in PK-15 cells, but it is unknown whether PTD-poMx1 exhibits antiviral activity in other porcine lines and it is efficacious for controlling CSFV infection in pigs in China. METHODS: Two porcine cell lines, ST and 3D4/21, were used to investigate in vitro antiviral activity of PTD-poMx1 against CSFV using confocal microscopy, western blot, flow cytometry, and real-time RT-PCR. Furthermore, in vivo antiviral activity of PTD-poMx1 was assessed by means of rectal temperature, clinical score, pathological lesion, white blood cell count, viral load, etc. RESULTS: PTD-poMx1 entered both cell lines within 3 h and maintained for 16 h, but did not affect CSFV binding and uptake. Viral titers and qRT-PCR data showed that PTD-poMx1 inhibited CSFV replication in both cell lines, showing significant antiviral activity after infection. Injection of PTD-poMx1 into CSFV-challenged pigs attenuated CSFV symptoms and viremia in dose-dependent manner but did not completely block virus replication within 14 days post challenge, suggesting that PTD-poMx1 confers partial protection against a lethal challenge. CONCLUSION: We demonstrated the anti-CSFV activity of PTD-poMx1 in vitro and in vivo. The results have shown that treatment with PTD-poMx1 alleviated symptoms and viral load in infected pigs. The results support our previous in vitro studies and suggest that PTD-poMx1 could be promising in reducing the clinical signs caused by CSFV.


Subject(s)
Classical Swine Fever Virus/immunology , Classical Swine Fever/prevention & control , Viral Vaccines/therapeutic use , tat Gene Products, Human Immunodeficiency Virus/genetics , Animals , Blotting, Western , Cell Line , Classical Swine Fever Virus/genetics , Enzyme-Linked Immunosorbent Assay/veterinary , Flow Cytometry/veterinary , In Vitro Techniques , Microscopy, Confocal/veterinary , Real-Time Polymerase Chain Reaction/veterinary , Swine , Transduction, Genetic/methods , Transduction, Genetic/veterinary , Vaccines, Synthetic/genetics , Vaccines, Synthetic/therapeutic use , Viral Vaccines/genetics , Viremia/veterinary
5.
J Anim Sci ; 92(1): 106-18, 2014 Jan.
Article in English | MEDLINE | ID: mdl-24166994

ABSTRACT

Undifferentiated germ cells have the capacity to develop into sperm capable of fertilizing oocytes and contributing genetic material to subsequent generations. The most primitive prepubertal undifferentiated germ cells include gonocytes and undifferentiated spermatogonia, including spermatogonial stem cells (SSC). Gonocytes, present in the testis at birth, differentiate into SSC, which maintain spermatogenesis for the remainder of the male's life. Because of their capacity to contribute to lifelong spermatogenesis, undifferentiated germ cells are attractive targets for genetic modification to produce transgenic animals, including cattle. To maximize the efficiency of genetic modification of bovine gonocytes and SSC, effective enrichment techniques need to be developed. Selection of bovine gonocytes using differential plating was improved 8-fold (P < 0.001) when using a combination of extracellular matrix proteins, including laminin, fibronectin, collagen type IV, and gelatin, compared to using laminin and gelatin alone. Selected cells labeled with PKH26 formed colonies of donor-derived germ cells after transplantation into recipient mouse testes, indicating putative stem cell function. Significantly more colonies (P < 0.001) per 1 × 10(5) viable transplanted cells were formed from isolated nonadherent cells (203 ± 23.2) compared to adherent (20 ± 2.7) or Percoll (45.5 ± 4.5) selected cells. After selection, some gonocytes were transduced using a lentiviral vector containing the transgene for the enhanced green fluorescent protein. Transduction efficiency was 17%. Collectively, these data demonstrate effective methods for the selection and genetic modification of bovine undifferentiated germ cells.


Subject(s)
Cattle , Cell Separation/methods , Lentivirus , Spermatogonia/metabolism , Stem Cells/metabolism , Transduction, Genetic/methods , Animals , Animals, Genetically Modified , Genetic Vectors , Green Fluorescent Proteins/metabolism , Male , Mice , Mice, Inbred BALB C , Mice, Nude , Spermatogonia/cytology , Stem Cells/cytology , Transduction, Genetic/veterinary
6.
J Vet Med Sci ; 76(4): 553-7, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24317268

ABSTRACT

Feline leukemia virus (FeLV) induces neoplastic and nonneoplastic diseases in cats. The transduction of cellular genes by FeLV is sometimes observed and associated with neoplastic diseases including lymphoma and sarcoma. Here, we report the first natural case of feline Notch2 transduction by FeLV in an infected cat with multicentric lymphoma and hypercalcemia. We cloned recombinant FeLVs harboring Notch2 in the env gene. Notch2 was able to activate expression of a reporter gene, similar to what was previously reported in cats with experimental FeLV-induced thymic lymphoma. Our findings suggest that the transduction of Notch2 strongly correlates with FeLV-induced lymphoma.


Subject(s)
Cat Diseases/genetics , Cat Diseases/virology , Leukemia Virus, Feline/physiology , Leukemia, Feline/genetics , Receptor, Notch2/metabolism , Transduction, Genetic/veterinary , Amino Acid Sequence , Animals , Base Sequence , Cats , Cloning, Molecular , DNA Primers/genetics , Female , Gene Components , Genes, env/genetics , HEK293 Cells , Humans , Leukemia Virus, Feline/genetics , Leukemia, Feline/virology , Luciferases , Molecular Sequence Data , Polymerase Chain Reaction/veterinary , Receptor, Notch2/genetics , Sequence Alignment , Sequence Analysis, DNA/veterinary
7.
Biol Reprod ; 88(1): 27, 2013 Jan.
Article in English | MEDLINE | ID: mdl-23221397

ABSTRACT

Genetic modification of germline stem cells (GSCs) is an alternative approach to generate large transgenic animals where transgenic GSCs are transplanted into a recipient testis to generate donor-derived transgenic sperm. The objective of the present study was to explore the application of viral vectors in delivering an enhanced green fluorescent protein (EGFP) transgene into GSCs for production of transgenic gametes through germ cell transplantation. Both adeno-associated virus (AAV)- and lentivirus (LV)-based vectors were effective in transducing pig GSCs, resulting in the production of transgenic sperm in recipient boars. Twenty-one boars treated with busulfan to deplete endogenous GSCs and nine nontreated boars received germ cell transplantation at 12 wk of age. Semen was collected from recipient boars from 5 to 7 mo posttransplantation when boars became sexually mature, and semen collection continued for as long as 5 yr for some boars. The percentage of ejaculates that were positive for the EGFP transgene ranged from 0% to 54.8% for recipients of AAV vector-transduced germ cells (n = 17) and from 0% to 25% for recipients of LV vector-transduced germ cells (n = 5). When semen from two AAV recipients was used for in vitro fertilization (IVF), 9.09% and 64.3% of embryos were transgenic. Semen collected from two LV-vector recipients produced 7.7% and 26.3% transgenic IVF embryos. Here, we not only demonstrated AAV-mediated GSC transduction in another large animal model (pigs) but also showed, to our knowledge for the first time, that LV-mediated GSC transduction resulted in transgene transmission in pigs.


Subject(s)
Germ Cells/transplantation , Green Fluorescent Proteins/metabolism , Swine/genetics , Transduction, Genetic/veterinary , Animals , Animals, Genetically Modified , Dependovirus , Gene Expression Regulation/physiology , Genetic Vectors , Germ Cells/metabolism , Green Fluorescent Proteins/genetics , Lentivirus , Male , Spermatozoa
8.
Am J Vet Res ; 73(8): 1178-85, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22849678

ABSTRACT

OBJECTIVE: To evaluate transduction efficiency of gene therapy for treatment of osteoarthritis in horses. SAMPLE: Cartilage and synovial tissues were aseptically collected from the stifle joints of 3 Thoroughbreds; horses were 3, 7, and 12 years old and free from sepsis and long-term drug treatment and were euthanized for reasons unrelated to joint disease. PROCEDURES: Gene transfer experiments were performed with 8 recombinant adeno-associated viral vector (rAAV) serotypes in monolayer-cultured equine chondrocytes, synovial cells, and mesenchymal stromal cells and in cartilage and synovial tissues. RESULTS: Serotypes rAAV2/5 and rAAV2/2 yielded the highest transduction efficiency in cultured cells 6 days after transduction. Synovial cells and mesenchymal stromal cells were more readily transduced than were chondrocytes. Serotype rAAV2/6.2 yielded the highest rate of gene expression in both cartilage and synovial tissues at 6 days after inoculation. However, at 30 and 60 days after inoculation, gene expression of serotypes rAAV2/2 and rAAV2/5 surpassed that of rAAV2/6.2 and all other serotypes. CONCLUSIONS AND CLINICAL RELEVANCE: Maximally expressing serotypes changed between 6 and 30 days in tissues; however, the most efficient serotypes for transduction of joint cells over time were also the most efficient serotypes for transduction of joint tissues. In addition, the low transduction efficiency of articular cartilage tissue was paralleled by a low transduction efficiency of isolated chondrocytes. This suggested that the typically low transduction efficiency of articular cartilage may be attributable in part to the low transduction efficiency of the chondrocytes and not solely a result of the dense cartilage matrix.


Subject(s)
Dependovirus/genetics , Horse Diseases/therapy , Joints/metabolism , Osteoarthritis/veterinary , Stifle/metabolism , Transduction, Genetic/veterinary , Animals , Cells, Cultured , Gene Expression Regulation, Viral , Genetic Therapy/methods , Genetic Therapy/veterinary , Genetic Vectors , Horse Diseases/metabolism , Horses , Joints/cytology , Osteoarthritis/metabolism , Osteoarthritis/therapy , Serotyping/veterinary , Stifle/cytology , Time Factors , Transgenes
9.
Vet Ophthalmol ; 15(5): 291-8, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22151250

ABSTRACT

OBJECTIVE: The aims of this study were (1) to determine the efficacy of adeno-associated vector serotype 5 (AAV5) for delivering gene therapy to canine corneal fibroblasts (CCFs) and myofibroblasts (CCMs) using enhanced green fluorescent protein (GFP) marker gene and (2) to evaluate the cytotoxicity of AAV5 to CCFs and CCMs using an in vitro model. METHODS: Healthy donor canine corneas were used to generate primary CCFs by growing cultures in minimal essential medium supplemented with 10% fetal bovine serum. Canine corneal myofibroblasts were produced by growing cultures in serum-free medium containing transforming growth factor ß1 (1 ng/mL). An AAV5 titer (6.5 × 10(12) µg/mL) expressing GFP under control of hybrid cytomegalovirus + chicken ß-actin promoters (AAV5-gfp) was used to transduce CCF and CCM cultures. Delivered gene expression in CCFs and CCMs was quantified using immunocytochemistry, fluorescent microscopy, and real-time PCR. Transduction efficacy of the AAV5 vector was determined by counting DAPI-stained nuclei and EGFP-positive cells in culture. Phase-contrast microscopy, trypan blue, and dUTP nick end labeling (TUNEL) assays were used to determine the toxicity and safety of AAV5 in this canine corneal model. RESULTS: Topical AAV5 application successfully transduced a significant population of CCFs (42.8%; P < 0.01) and CCMs (28%; P < 0.01). Tested AAV5 did not affect CCF or CCM phenotype or cellular viability and did not cause significant cell death. CONCLUSIONS: The tested AAV5 is an effective and safe vector for canine corneal gene therapy in this in vitro model. In vivo studies are warranted.


Subject(s)
Adenoviridae , Cornea/cytology , Dogs/physiology , Fibroblasts/metabolism , Myofibroblasts/metabolism , Transduction, Genetic/veterinary , Animals , Cells, Cultured , Gene Expression Regulation , Genetic Vectors/standards , Green Fluorescent Proteins/genetics , Immunohistochemistry , Real-Time Polymerase Chain Reaction , Transduction, Genetic/methods
10.
J Anim Sci ; 89(9): 2708-16, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21478453

ABSTRACT

Since the first reports on isolation of pluripotent mouse embryonic stem (ES) cells 3 decades ago, there have been numerous attempts to derive ES cell lines from commercially important livestock species with limited success. The recent discovery that ectopic expression of a handful of stem cell-related genes was capable of inducing pluripotency in rodents and primates provided a novel approach to derivation of pluripotent stem cell lines. We used this approach in cattle and demonstrated that the ectopic expression of POU5F1 (also known as Oct4), SOX2, KLF4, and c-MYC alone was not sufficient for stable induction of pluripotency in bovine adult fibroblasts and that the additional expression of NANOG to the reprogramming cocktail was essential for the generation of stable bovine (b) induced pluripotent stem (iPS) cells. The resulting biPS cells were characterized by reverse-transcription PCR for a panel of ES marker genes. Immunocytochemical localization of POU5F1, SSEA-1, SSEA-4, and colorimetric alkaline phosphatase activity was measured in the iPS clones. The differentiation potential of the biPS cells was determined in vitro by expression of differentiation markers in embryoid bodies. Injection of biPS into immunocompromised mice resulted in teratomas containing cell types of the 3 germ lineages. This study reports the first generation of bovine induced pluripotent cell lines and paves the way for the use of biPS cells for biotechnological and agricultural purposes.


Subject(s)
Cattle/genetics , Homeodomain Proteins/genetics , Induced Pluripotent Stem Cells/metabolism , Animals , Cell Differentiation/genetics , Fluorescent Antibody Technique/veterinary , Gene Expression Regulation, Developmental/genetics , Genes, myc/genetics , Kruppel-Like Factor 4 , Kruppel-Like Transcription Factors/genetics , Octamer Transcription Factor-3/genetics , Reverse Transcriptase Polymerase Chain Reaction/veterinary , SOXB1 Transcription Factors/genetics , Transduction, Genetic/veterinary
11.
Insect Mol Biol ; 19(5): 653-8, 2010 Oct.
Article in English | MEDLINE | ID: mdl-20546039

ABSTRACT

Honey bees (Apis mellifera L.) play a vital role in agriculture as pollinators, and serve as model organisms of social behaviour and immunity. The lack of both immortalized cell lines and methods to introduce recombinant DNA reliably into primary cells hinders cellular and molecular studies in this organism. We hereby demonstrate the expression of a GFP gene delivered by lentivirus transduction to cultured embryonic cells. The success of this approach indicates that viral transduction could be used to deliver constitutively active oncogenes in order to immortalize honey bee cells. We were able to revive cells successfully after several months of cryogenic storage and we show how the proteome varies between freshly collected and cultured embryonic cells.


Subject(s)
Bees/chemistry , Bees/genetics , Insect Proteins/analysis , Proteome/analysis , Transduction, Genetic/veterinary , Animals , Cells, Cultured , Gene Expression , Genetic Vectors , Green Fluorescent Proteins/genetics , Insect Proteins/genetics , Lentivirus/genetics , Transduction, Genetic/methods , Transgenes
12.
Theriogenology ; 74(5): 805-16.e1, 2010 Sep 15.
Article in English | MEDLINE | ID: mdl-20570335

ABSTRACT

The use of genetically modified germ cells is an ideal system to induce transgenesis in birds; the primordial germ cell (PGC) is the most promising candidate for this system. In the present study, we confirmed the practical application of this system using lentivirus-transduced chicken gonadal PGCs (gPGCs). Embryonic gonads were collected from 5.5-d old Korean Oge chickens (black feathers). The gPGC population was enriched (magnetic-activated cell sorting technique) and then they were transduced with a lentiviral vector expressing enhanced green fluorescent protein (eGFP), under the control of the Rous sarcoma virus (RSV) promoter. Subsequently, the eGFP-transduced PGCs were transplanted into blood vessels of 2.5-d-old embryonic White Leghorn (white feathers). Among 21 germline chimeric chickens, one male produced transgenic offspring (G(1) generation), as demonstrated by testcross and genetic analysis. A homozygous line was produced and maintained through the G(3) generation. Based on serum biochemistry, there were no significant physiological differences between G(3) homozygotes and non-transgenic chickens. However, since eGFP transgene expression in G(3) chickens varied among tissues, it was further characterized by Western blotting and ELISA. Furthermore, there were indications that DNA methylation may have affected tissue-specific expression of transgenes in chickens. In conclusion, the PGC-mediated approach used may be an efficient tool for avian transgenesis, and transgenic chickens could provide a useful model for investigating regulation of gene expression.


Subject(s)
Chick Embryo/cytology , Chickens/genetics , CpG Islands , DNA Methylation , Gene Expression , Germ Cells/transplantation , Transgenes , Animals , Animals, Genetically Modified/blood , Animals, Genetically Modified/metabolism , Blotting, Western , Chickens/blood , Chimera , Enzyme-Linked Immunosorbent Assay , Genetic Vectors , Green Fluorescent Proteins/analysis , Lentivirus/genetics , Transduction, Genetic/veterinary
13.
Reprod Domest Anim ; 44(4): 612-20, 2009 Aug.
Article in English | MEDLINE | ID: mdl-18694428

ABSTRACT

Spermatogonial transplantation will provide a new way to study spermatogenesis in domestic animals, disseminate male genetics and produce transgenic animals, if efficiency can be improved. We evaluated a 'surgical' method for transplanting donor cells into testes of ram lambs, where the head of the epididymis is reflected, and a catheter introduced into the extra-testicular rete testis. We also tested transduction of ram spermatogonia with a lentiviral (LV) vector as a means to identify permanent colonization, and introduce genes into donor cells. Eight ram lambs, 11- to 13-week olds, were the recipients: in five, spermatogonia were injected into one testis, and the contralateral testis was an un-manipulated control: in two, spermatogonia were injected into one testis and the contralateral was sham-injected: in one, both testes were injected. Six lambs received spermatogonia labelled with a cell-tracking dye and these were collected 1 or 2 weeks after transplantation; three lambs received spermatogonia transduced with a LV vector driving the expression of enhanced Green Fluorescence Protein and these were collected after 2 months. Donor cells were detected by immunohistochemistry in tubules of seven of nine recipient testes. Approximately 22% of tubule cross-sections contained donor cells immediately after transplantation, and 0.2% contained virally transduced cells 2 months after transplantation. The onset of spermatogenesis was delayed, and there were lesions in both injected and sham-injected testes. Despite the effects of the surgery, elongated spermatids were present in one recipient testis 2 months after surgery. The results suggest that, after modifying the surgical and transduction techniques, this approach will be a means to produce good colonization by donor spermatogonia in sheep testes.


Subject(s)
Rete Testis , Sheep , Spermatogonia/metabolism , Spermatogonia/transplantation , Transduction, Genetic/veterinary , Animals , Cell Survival , Gene Expression , Genetic Vectors , Green Fluorescent Proteins/genetics , Immunohistochemistry/veterinary , Lentivirus/genetics , Lentivirus/growth & development , Male , Seminiferous Tubules/cytology , Spermatogenesis
14.
Vet Immunol Immunopathol ; 125(3-4): 368-74, 2008 Oct 15.
Article in English | MEDLINE | ID: mdl-18584878

ABSTRACT

The CD79alpha (immunoglobulin alpha, Igalpha), a part of B cell receptor (BCR) complex, forms a heterodimer with CD79beta (Igbeta) and plays an important role in the B cell signaling. In this study, we have cloned pig Cd79a cDNA using RT-PCR and determined the complete cDNA sequence of pig Cd79a. Pig Cd79a cDNA contains an open reading frame (672bp) encoding 223 amino acids. The putative amino acid identity of pig CD79alpha with those of human, cattle and mouse are 70.4, 81.4, and 67.7%, respectively. Alignment of the CD79alpha amino acid sequence with those of mammalian species showed that the extracellular domain is the most divergent, whereas transmembrane region and cytoplasmic tail including immunoreceptor tyrosine-based activation motif (ITAM) are largely conserved. Pig Cd79a mRNA was detected mainly in lymphoid tissues by RT-PCR. The highest level of Cd79a mRNA expression was observed in mesenteric lymph node and spleen. Relatively low level of Cd79a mRNA expression was observed in lung, thymus and small intestine. The lowest level of Cd79a mRNA expression was observed in large intestine. Flow cytometry analyses demonstrated that human CD79alpha antibody recognizes a CD79alpha in pig B cells. Further, immunohistochemistry analysis using human CD79alpha antibody on pig spleen was revealed that CD79alpha is strongly expressed in the follicular mantle zone rather than in the germinal center. Future study will be focused on defining the functional role of CD79alpha during the course of pig infectious diseases and the formation of neoplasm.


Subject(s)
CD79 Antigens/biosynthesis , CD79 Antigens/genetics , Swine/genetics , Amino Acid Sequence , Animals , Base Sequence , CHO Cells , Cloning, Molecular , Cricetinae , Cricetulus , Female , Immunohistochemistry/veterinary , Lymph Nodes/immunology , Male , Molecular Sequence Data , RNA, Messenger/biosynthesis , RNA, Messenger/genetics , Reverse Transcriptase Polymerase Chain Reaction/veterinary , Sequence Alignment , Spleen/immunology , Swine/immunology , Transduction, Genetic/veterinary
15.
Vet Microbiol ; 129(3-4): 418-25, 2008 Jun 22.
Article in English | MEDLINE | ID: mdl-18187273

ABSTRACT

Antimicrobial resistance of Salmonella spp., especially resistance mediated by extended spectrum beta-lactamases (ESBL), is a growing public health concern. Understanding the mechanisms through which Salmomella spp. acquire the resistance genes can lead to the development of intervention and mitigation strategies. Thirty-one Salmonella isolates of bovine origin were analyzed by serotyping, antimicrobial susceptibility testing, phage induction and bacterial host range determination, and phage transduction of antimicrobial resistance. The Salmonella isolates consisted of 12 serovars. Resistance to 1 or more antibiotics was detected in 12 isolates. Inducible phages were recovered from 19 Salmonella (61%) by spot lysis assay. Of the 19 phage samples, 13 were able to multiply in 2 or more Salmonella of various serovars. A cross-serovar transduction of antimicrobial resistance was observed from S. Heidelberg to S. Typhimurium. Transfection of an antimicrobial-susceptible strain of S. Typhimurium with a phage propagated in a S. Heidelberg resistant to multiple beta-lactam antibiotics and tetracycline resulted in independent acquisition of bla(CMY-2), tet(A), and tet(B). These data indicate that inducible phages are common in Salmonella of bovine origin, many of them demonstrate a broad host range, and wild-type phage mediated transduction may contribute to the dissemination of antimicrobial resistance, including the resistance mediated by ESBL.


Subject(s)
Salmonella enterica/enzymology , Salmonella typhimurium/enzymology , Transduction, Genetic , beta-Lactam Resistance/genetics , beta-Lactamases/genetics , Animals , Anti-Bacterial Agents/pharmacology , Antiporters/genetics , Bacterial Proteins/genetics , Bacteriophage Typing , Drug Resistance, Multiple, Bacterial/genetics , Genes, Bacterial , Microbial Sensitivity Tests/veterinary , Salmonella enterica/genetics , Salmonella typhimurium/genetics , Transduction, Genetic/veterinary , Transformation, Bacterial/genetics
16.
Acta Vet Scand ; 49: 14, 2007 May 08.
Article in English | MEDLINE | ID: mdl-17488512

ABSTRACT

BACKGROUND: Salmonella enterica serotype Gallinarum (S. Gallinarum) remains an important pathogen of poultry, especially in developing countries. There is a need to develop effective and safe vaccines. In the current study, the effect of crp deletion was investigated with respect to virulence and biochemical properties and the possible use of a deletion mutant as vaccine candidate was preliminarily tested. METHODS: Mutants were constructed in S. Gallinarum by P22 transduction from Salmonella Typhimurium (S. Typhimurium) with deletion of the crp gene. The effect was characterized by measuring biochemical properties and by testing of invasion in a chicken loop model and by challenge of six-day-old chickens. Further, birds were immunized with the deleted strain and challenged with the wild type isolate. RESULTS: The crp deletions caused complete attenuation of S. Gallinarum. This was shown by ileal loop experiments not to be due to significantly reduced invasion. Strains with such deletions may have vaccine potential, since oral inoculatoin with S. Gallinarum Deltacrp completely protected against challenge with the same dose of wild type S. Gallinarum ten days post immunization. Interestingly, the mutations did not cause the same biochemical and growth changes to the two biotypes of S. Gallinarum. All biochemical effects but not virulence could be complemented by providing an intact crp-gene from S. Typhimurium on the plasmid pSD110. CONCLUSION: Transduction of a Tn10 disrupted crp gene from S. Typhimurium caused attenuation in S. Gallinarum and mutated strains are possible candidates for live vaccines against fowl typhoid.


Subject(s)
Chickens , Cyclic AMP Receptor Protein/genetics , Gene Deletion , Salmonella Infections, Animal/prevention & control , Salmonella Vaccines , Salmonella enterica , Amino Acid Sequence , Animals , Base Sequence , Biological Assay/veterinary , Cyclic AMP Receptor Protein/physiology , Female , Molecular Sequence Data , RNA, Bacterial/analysis , Reverse Transcriptase Polymerase Chain Reaction/veterinary , Salmonella Vaccines/immunology , Salmonella enterica/genetics , Salmonella enterica/immunology , Salmonella enterica/pathogenicity , Salmonella typhimurium/genetics , Sequence Alignment , Transduction, Genetic/methods , Transduction, Genetic/veterinary , Vaccines, Attenuated/immunology , Virulence Factors/genetics
17.
Am J Vet Res ; 68(1): 95-100, 2007 Jan.
Article in English | MEDLINE | ID: mdl-17199425

ABSTRACT

OBJECTIVE: To induce chemoresistance in a normal canine cell line through the transduction of the canine multidrug resistance 1 gene (mdr1). SAMPLE POPULATION: Madin-Darby canine kidney (MDCK) epithelial cell line. PROCEDURES: The full-length canine mdr1 cDNA clone isolated in our laboratory was inserted into a Moloney murine leukemia virus-based vector to construct the retroviral vector, pLNC-cMDR1. After retroviral transduction of pLNC-cMDR1 into MDCK cells, the expression and function of the P-glycoprotein, a product of mdr1, were assessed by immunoblotting, measurement of rhodamine123 (Rh123) retention, and drug sensitivity assays. RESULTS: P-glycoprotein was strongly expressed in cells transduced with pLNC-cMDR1. This P-glycoprotein was fully functional, as demonstrated by the decreased Rh123 retention and the increased resistance to chemotherapeutic drugs. Measured as 50% inhibitory concentrations, resistance increased 59 times to vincristine and 25 times to doxorubicin in MDCK cells after transduction of pLNC-cMDR1. CONCLUSIONS AND CLINICAL RELEVANCE: Transduction of canine mdr1 is an effective method for inducing chemoresistance in normal canine cells. This system may be applicable to the induction of drug resistance in hematopoietic cells.


Subject(s)
ATP Binding Cassette Transporter, Subfamily B, Member 1/genetics , Dogs/genetics , Retroviridae/genetics , Transduction, Genetic/veterinary , ATP Binding Cassette Transporter, Subfamily B, Member 1/biosynthesis , ATP Binding Cassette Transporter, Subfamily B, Member 1/metabolism , Animals , Antineoplastic Agents/pharmacology , Base Sequence , COS Cells , Cell Line , Chlorocebus aethiops , DNA, Complementary/genetics , Dogs/metabolism , Doxorubicin/pharmacology , Drug Resistance, Neoplasm , Flow Cytometry/veterinary , Fluorescent Dyes/metabolism , Genetic Vectors/genetics , Inhibitory Concentration 50 , Molecular Sequence Data , Rhodamine 123/metabolism , Sequence Analysis, DNA , Vincristine/pharmacology
18.
Vet Res Commun ; 30(8): 881-901, 2006 Nov.
Article in English | MEDLINE | ID: mdl-17139538

ABSTRACT

We have used a murine MSCV-based bicistronic retroviral vector, containing the common gamma chain (gammac) and enhanced green fluorescent protein (EGFP) cDNAs, to optimize retroviral transduction of canine cells, including an adherent canine thymus fibroblast cell line, Cf2Th, as well as normal canine CD34(+) bone marrow (BM) cells. Both canine cell types were shown to express Ram-1 (the amphotropic retroviral receptor) mRNA. Supernatants containing infectious viruses were produced using both stable (PA317) and transient (Phoenix cells) amphotropic virus producer cell lines. Centrifugation (spinfection) combined with the addition of polybrene produced the highest transduction efficiencies, infecting approximately 75% of Cf2Th cells. An average of 11% of highly enriched canine CD34(+) cells could be transduced in a protocol that utilized spinfection and plates coated with the fibronectin fragment CH-296 (Retronectin). Indirect assays showed the vector-encoded canine gammac cDNA produced a gammac protein that was expressed on the cell surface of transduced cells. This strategy may result in the transduction of sufficient numbers of CD34(+) BM cells to make the treatment of canine X-linked severe combined immunodeficiency and other canine genetic diseases feasible.


Subject(s)
Antigens, CD34/metabolism , Bone Marrow Cells/metabolism , Dogs , Genetic Vectors/genetics , Stem Cells/virology , Transduction, Genetic/veterinary , Animals , Cell Line , Fibroblasts , Genes/genetics , Mice , Retroviridae/genetics , Thymus Gland/cytology , Transduction, Genetic/methods
19.
Berl Munch Tierarztl Wochenschr ; 115(9-10): 355-9, 2002.
Article in English | MEDLINE | ID: mdl-12357672

ABSTRACT

Salmonella bacteriophages seem to mediate horizontal transfer of virulence functions among Salmonella strains in two different ways: by general transduction and also by lysogenic conversion. The majority of wild phages isolated from Salmonella strains belong to the P22 like phages and were able to transduce. Our data show that the lysogenic conversion is generally accompanied by changes in the susceptibility to the typing phages used for epidemiological purposes. Similar phage type conversions to S. Typhimurium DT104 could be detected upon lysogenization with two other S. Typhimurium strains. For some S. Typhimurium strains the typical phage pattern is actually associated with alterations of virulence characteristics. For example, all tested wild type isolates of phage types DT49 and DT204 were found to be SopE phi-lysogens. The Anderson typing phages interfere with the prophages and/or cryptic phages and so the complex genetic short-term evolution can be demonstrated in the lab. This is one reason for the successful application of phage typing in Salmonella epidemiology since the 50s.


Subject(s)
Gene Transfer, Horizontal , Salmonella Phages/physiology , Salmonella typhimurium/pathogenicity , Transduction, Genetic/veterinary , Bacteriophage Typing , Lysogeny , Salmonella Phages/genetics , Salmonella typhimurium/classification , Salmonella typhimurium/genetics , Virulence
SELECTION OF CITATIONS
SEARCH DETAIL
...